Efgartigimod led to statistically significant improvement in key symptoms of ocular myasthenia gravis compared with placebo in a phase 3 trial.

Driving global innovation through precision sensing technology, intelligent data integration, and sustainable water ...

Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on therapies for immune and inflammatory diseases, today announced positive ...

We are very pleased to have aligned with the FDA on the path forward for our MAGNITUDE clinical trial, with measures designed ...

Anifrolumab yielded positive outcomes, including remission in 26% of patients, at 6 months across a real-word, multicenter cohort of patients with systemic lupus erythematosus, according to data ...

“With the brepocitinib CS program now moving into Phase 3 alongside the dermatomyositis and non-infectious uveitis programs, Priovant continues to advance our goal of developing brepocitinib as a ...

Legislation to revise Virginia’s medical marijuana labeling standards and explicitly allow home delivery received unanimous approval today by the Senate Rehabilitation and Social Services Committee.

The Marine Corps just killed height-and-weight screenings. A completely new method is now the standard for every Marine's ...

Researchers showed that pomegranate fruit extract contains substantial levels of non-extractable polyphenols bound within its ...

Orforglipron, which could be approved for obesity next quarter, proved superior at cutting blood sugar and body weight — but at the expense of higher side effect rates.

The U.S. Food and Drug Administration on Wednesday approved Eton Pharmaceuticals' first-of-its-kind liquid therapy for a rare hormonal disorder, offering a more precise dosing option for families ...

Major League Baseball can’t implement the Automated Ball-Strike (ABS) Challenge System this season without knowing every hitter’s precise height, right down to the millimeter. So, like a flashback to ...